rs1060500603
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_172107.4(KCNQ2):c.2173_2179dupCGCCAGG(p.Gly727AlafsTer140) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. G727G) has been classified as Likely benign.
Frequency
Consequence
NM_172107.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 7Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- neonatal encephalopathy with non-epileptic myoclonusInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neonatal-onset developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- seizures, benign familial neonatal, 1Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- seizures, benign familial neonatal, 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- benign familial neonatal-infantile seizuresInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- benign neonatal seizuresInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- malignant migrating partial seizures of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNQ2 | NM_172107.4 | c.2173_2179dupCGCCAGG | p.Gly727AlafsTer140 | frameshift_variant | Exon 17 of 17 | ENST00000359125.7 | NP_742105.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNQ2 | ENST00000359125.7 | c.2173_2179dupCGCCAGG | p.Gly727AlafsTer140 | frameshift_variant | Exon 17 of 17 | 1 | NM_172107.4 | ENSP00000352035.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy Pathogenic:1
This sequence change inserts 7 nucleotides in exon 17 of the KCNQ2 mRNA (c.2173_2179dupCGCCAGG), causing a frameshift at codon 727. This creates a premature translational stop signal in the last exon of the KCNQ2 mRNA (p.Gly727Alafs*140). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 145 amino acids of the KCNQ2 protein. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a KCNQ2-related disease. In summary, this is a novel frameshift variant that occurs upstream of a previously described pathogenic frameshift variant. This evidence indicates that the variant is also pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. A different frameshift downstream of this variant (p.Cys744Leufs*91) has been determined to be pathogenic (PMID: 23692823). This suggests that disruption of this region of the KCNQ2 protein is causative of disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at